» Articles » PMID: 35265220

Outer Hair Cell Gene Editing Ameliorates Progressive Hearing Loss in Dominant-negative Murine Model

Overview
Journal Theranostics
Date 2022 Mar 10
PMID 35265220
Authors
Affiliations
Soon will be listed here.
Abstract

Outer hair cell (OHC) degeneration is a major cause of progressive hearing loss and presbycusis. Despite the high prevalence of these disorders, targeted therapy is currently not available. We generated a mouse model harboring to recapitulate DFNA2, a common genetic form of progressive hearing loss accompanied by OHC degeneration. After comprehensive optimization of guide RNAs, Cas9s, vehicles, and delivery routes, we applied gene editing strategy to disrupt the dominant-negative allele in and prevent progressive hearing loss. gene editing using a dual adeno-associated virus package targeting OHCs significantly improved auditory thresholds in auditory brainstem response and distortion-product otoacoustic emission. In addition, we developed a new live-cell imaging technique using thallium ions to investigate the membrane potential of OHCs and successfully demonstrated that mutant allele disruption resulted in more hyperpolarized OHCs, indicating elevated KCNQ4 channel activity. These findings can facilitate the development of targeted therapies for DFNA2 and support the use of CRISPR-based gene therapy to rectify defects in OHCs.

Citing Articles

A KCNQ4 Gene Variant (c.701A > G; p.His234Arg) in a Chinese Family With Nonsyndromic Deafness 2A.

Gong G, Huang C, Jin H, Zhang Z, Yang C, Yang G Mol Genet Genomic Med. 2025; 13(3):e70075.

PMID: 40052770 PMC: 11886983. DOI: 10.1002/mgg3.70075.


Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model.

Nam Y, Gi E, Ko Y, Lee S, Cho H PLoS One. 2025; 20(2):e0316033.

PMID: 39908276 PMC: 11798502. DOI: 10.1371/journal.pone.0316033.


Gene therapy for hearing loss: challenges and the promise of cellular plasticity and epigenetic modulation.

Das S, Manor U Front Neurol. 2024; 15:1511938.

PMID: 39722701 PMC: 11668650. DOI: 10.3389/fneur.2024.1511938.


From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine.

Xu W, Zhang S, Qin H, Yao K J Transl Med. 2024; 22(1):1133.

PMID: 39707395 PMC: 11662623. DOI: 10.1186/s12967-024-05957-3.


Inner Ear Gene Therapy: An Overview from Bench to Bedside.

Gadenstaetter A, Krumpoeck P, Landegger L Mol Diagn Ther. 2024; 29(2):161-181.

PMID: 39625555 PMC: 11861411. DOI: 10.1007/s40291-024-00759-1.


References
1.
Van Eyken E, Van Laer L, Fransen E, Topsakal V, Lemkens N, Laureys W . KCNQ4: a gene for age-related hearing impairment?. Hum Mutat. 2006; 27(10):1007-16. DOI: 10.1002/humu.20375. View

2.
Liu S, Wang S, Zou L, Li J, Song C, Chen J . TMC1 is an essential component of a leak channel that modulates tonotopy and excitability of auditory hair cells in mice. Elife. 2019; 8. PMC: 6853638. DOI: 10.7554/eLife.47441. View

3.
Kim Y, Ramakrishna S, Kim H, Kim J . Enrichment of cells with TALEN-induced mutations using surrogate reporters. Methods. 2014; 69(1):108-17. DOI: 10.1016/j.ymeth.2014.04.012. View

4.
Truong D, Kuhner K, Kuhn R, Werfel S, Engelhardt S, Wurst W . Development of an intein-mediated split-Cas9 system for gene therapy. Nucleic Acids Res. 2015; 43(13):6450-8. PMC: 4513872. DOI: 10.1093/nar/gkv601. View

5.
Ueberfuhr M, Fehlberg H, Goodman S, Withnell R . A DPOAE assessment of outer hair cell integrity in ears with age-related hearing loss. Hear Res. 2015; 332:137-150. DOI: 10.1016/j.heares.2015.11.006. View